Table 2 Factors associated with Kaposi Sarcoma at HIV care enrollment in Jos, Nigeria (2006–2017)
Characteristics | Unadjusted analysis | Adjusted analysis | ||
|---|---|---|---|---|
OR (95% CI) | P value | OR (95% CI) | P value | |
Year of initiation of HIV care | ||||
2006–2008 | Reference | Reference | ||
2009–2011 | 4.92 (3.03–7.98) | < 0.001 | 5.07 (3.12–8.24) | < 0.001 |
2012–2014 | 2.51 (1.36–4.63) | 0.003 | 2.50 (1.35–4.62) | 0.003 |
2015–2017 | 2.51 (1.17–5.36) | 0.018 | 2.47 (1.15–5.30) | 0.020 |
Sex | ||||
Male | Reference | Reference | ||
Female | 0.45 (0.30–0.67) | < 0.001 | 0.53 (0.34–0.82) | 0.004 |
Age group, years | ||||
< 30 | Reference | Reference | ||
30–39 | 1.76 (1.03–3.03) | 0.038 | 1.43 (0.82–2.48) | 0.209 |
≥ 40 | 1.87 (1.07–3.29) | 0.028 | 1.34 (0.73–2.43) | 0.342 |
Baseline CD4 T-cell count, per 100 cells/mm3 increase | 0.85 (0.74–0.97) | 0.02 | 0.87 (0.76–0.99) | 0.04 |